Manish A. Shah

Manish Shah practices at Robert Wood Johnson University Hospital in New Brunswick, New Jersey, part of RWJBarnabas Health.

Manish Shah's NPI, 1669670071, was assigned on July 6, 2007. Manish Shah holds New Jersey license 25MA08309300.

Manish Shah's primary practice is Robert Wood Johnson University Hospital, at One Robert Wood Johnson Place, New Brunswick, NJ 08901 in Middlesex County. The practice phone is (732) 828-3000. Manish Shah also practices at Robert Wood Johnson University Hospital - New Brunswick, 1 Robert Wood Johnson Pl, New Brunswick, NJ 08901.

Manish Shah's primary practice is Robert Wood Johnson University Hospital in New Brunswick, New Jersey, part of RWJBarnabas Health. The medical group on file is RWJBarnabas Health Medical Group. Dmand AI also links Manish Shah to 4 more medical groups and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Manish Shah practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Manish Shah's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Manish Shah is licensed in New Jersey.

CMS data shows 1,951 Medicare services from Manish Shah across 5 procedure codes in 2024, for 445 Medicare patients. Medicare paid $174,495 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 445 Medicare patients who saw Manish Shah in 2024. The largest group is 75 to 84, with 165 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Manish Shah's median patient age at 73, with 48% women.

In 2024, Manish Shah wrote 563 Medicare Part D claims for 219 patients. 88% of them were for generic drugs. CMS names the drug for 240 of them, across 11 drugs with 11 or more claims each, at $13,224 in total drug cost. In 2023, CMS named 289 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Manish Shah for performance year 2024, reported as part of a group. Manish Shah accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 98 papers to Manish Shah, published from 2014 to 2025. 2019 was the busiest year, with 17. The most frequent topics are Esophageal Neoplasms, Adenocarcinoma and Antineoplastic Combined Chemotherapy Protocols. Manish Shah has published most often in Future Oncol. Manish Shah's most frequent co-authors are Manish A. Shah, MD, Zev Aryeh Wainberg, MD and Uqba Khan, MD.

CMS Open Payments shows 66 general payments to Manish Shah from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 52% of the total. Daiichi Sankyo Inc. paid the most, $2,650.